RPG Life Sciences Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for RPG Life Sciences.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 17.8% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
There May Be Some Bright Spots In RPG Life Sciences' (NSE:RPGLIFE) Earnings
Nov 15
RPG Life Sciences Limited's (NSE:RPGLIFE) Shares Climb 26% But Its Business Is Yet to Catch Up
Oct 18Investors Appear Satisfied With RPG Life Sciences Limited's (NSE:RPGLIFE) Prospects As Shares Rocket 30%
Jul 25RPG Life Sciences' (NSE:RPGLIFE) Earnings Are Of Questionable Quality
May 08RPG Life Sciences (NSE:RPGLIFE) Is Increasing Its Dividend To ₹12.00
Jul 11Estimating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Sep 05Shareholders May Be More Conservative With RPG Life Sciences Limited's (NSE:RPGLIFE) CEO Compensation For Now
Aug 24A Look At The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Jun 14Are Strong Financial Prospects The Force That Is Driving The Momentum In RPG Life Sciences Limited's NSE:RPGLIFE) Stock?
Feb 09Can You Imagine How RPG Life Sciences' (NSE:RPGLIFE) Shareholders Feel About The 75% Share Price Increase?
Jan 13RPG Life Sciences (NSE:RPGLIFE) Is Growing Earnings But Are They A Good Guide?
Dec 23
Declining Stock and Solid Fundamentals: Is The Market Wrong About RPG Life Sciences Limited (NSE:RPGLIFE)?
Nov 11Estimating The Fair Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Oct 21Did Business Growth Power RPG Life Sciences' (NSE:RPGLIFE) Share Price Gain of 126%?
Sep 28What Makes RPG Life Sciences Limited (NSE:RPGLIFE) A Great Dividend Stock?
Aug 31With RPG Life Sciences Limited (NSE:RPGLIFE) It Looks Like You'll Get What You Pay For
Aug 11What You Can Learn From RPG Life Sciences Limited's (NSE:RPGLIFE) P/E
Jul 28Calculating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Jul 10In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as RPG Life Sciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 6,183 | 707 | 444 | 1,065 | N/A |
| 6/30/2024 | 5,997 | 923 | N/A | N/A | N/A |
| 3/31/2024 | 5,821 | 877 | 251 | 944 | N/A |
| 12/31/2023 | 5,736 | 848 | N/A | N/A | N/A |
| 9/30/2023 | 5,505 | 774 | 354 | 896 | N/A |
| 6/30/2023 | 5,317 | 715 | N/A | N/A | N/A |
| 3/31/2023 | 5,128 | 676 | 581 | 908 | N/A |
| 12/31/2022 | 4,981 | 648 | N/A | N/A | N/A |
| 9/30/2022 | 4,831 | 603 | 343 | 612 | N/A |
| 6/30/2022 | 4,610 | 561 | N/A | N/A | N/A |
| 3/31/2022 | 4,402 | 515 | 408 | 648 | N/A |
| 12/31/2021 | 4,291 | 509 | N/A | N/A | N/A |
| 9/30/2021 | 4,211 | 491 | 696 | 808 | N/A |
| 6/30/2021 | 4,056 | 445 | N/A | N/A | N/A |
| 3/31/2021 | 3,891 | 400 | 498 | 583 | N/A |
| 12/31/2020 | 3,851 | 361 | N/A | N/A | N/A |
| 9/30/2020 | 3,718 | 311 | 239 | 316 | N/A |
| 6/30/2020 | 3,732 | 297 | N/A | N/A | N/A |
| 3/31/2020 | 3,756 | 290 | 394 | 502 | N/A |
| 12/31/2019 | 3,557 | 276 | N/A | N/A | N/A |
| 9/30/2019 | 3,523 | 249 | 458 | 675 | N/A |
| 6/30/2019 | 3,443 | 173 | N/A | N/A | N/A |
| 3/31/2019 | 3,302 | 108 | 261 | 458 | N/A |
| 12/31/2018 | 3,448 | 105 | N/A | N/A | N/A |
| 9/30/2018 | 3,495 | 107 | N/A | N/A | N/A |
| 6/30/2018 | 3,485 | 149 | N/A | N/A | N/A |
| 3/31/2018 | 3,440 | 135 | N/A | 147 | N/A |
| 12/31/2017 | 3,360 | 141 | N/A | N/A | N/A |
| 9/30/2017 | 3,062 | 97 | N/A | N/A | N/A |
| 6/30/2017 | 2,948 | 62 | N/A | N/A | N/A |
| 3/31/2017 | 2,936 | 121 | N/A | 73 | N/A |
| 12/31/2016 | 3,029 | 229 | N/A | N/A | N/A |
| 9/30/2016 | 3,095 | 270 | N/A | N/A | N/A |
| 6/30/2016 | 2,993 | 194 | N/A | N/A | N/A |
| 3/31/2016 | 2,552 | 84 | N/A | 328 | N/A |
| 12/31/2015 | 2,758 | 141 | N/A | N/A | N/A |
| 9/30/2015 | 2,609 | 119 | N/A | N/A | N/A |
| 6/30/2015 | 2,501 | 20 | N/A | N/A | N/A |
| 3/31/2015 | 2,423 | 10 | N/A | -20 | N/A |
| 12/31/2014 | 2,290 | -42 | N/A | N/A | N/A |
| 9/30/2014 | 2,273 | -98 | N/A | N/A | N/A |
| 6/30/2014 | 2,312 | -1 | N/A | N/A | N/A |
| 3/31/2014 | 2,356 | 534 | N/A | -56 | N/A |
| 12/31/2013 | 2,400 | 613 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if RPGLIFE's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if RPGLIFE's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if RPGLIFE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if RPGLIFE's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if RPGLIFE's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if RPGLIFE's Return on Equity is forecast to be high in 3 years time